Aldevron Executive and Leadership Team

Michael Chambers, the Founder & Chief Executive Officer at Aldevron, directs the company's overarching strategy and vision. Chambers guides Aldevron's expansion in developing and manufacturing plasmid DNA, proteins, enzymes, and antibodies, critical components for biotechnology advancements. This leadership role involves setting the strategic direction for research and development initiatives, ensuring Aldevron remains at the forefront of biological material production. By fostering a culture of innovation, Michael Chambers drives the company's commitment to supporting global health and scientific research. The Chief Executive Officer's focus extends to operational excellence and market positioning, solidifying Aldevron's reputation as a key player in the biotechnology sector. Chambers' strategic oversight ensures the company's continued growth and impact within the pharmaceutical manufacturing industry.

Courtney Tornow, the Chief Financial Officer at Aldevron, manages all financial operations and strategic financial planning. Tornow oversees budgeting, forecasting, and financial reporting, ensuring the fiscal health and stability of the company. This role is critical in supporting Aldevron's growth in developing and manufacturing plasmid DNA, proteins, enzymes, and antibodies. The Chief Financial Officer analyzes financial performance, identifies investment opportunities, and manages risk to optimize profitability. By ensuring robust financial controls, Courtney Tornow supports the company's mission to advance biotechnology and impact global health. Tornow's expertise guides financial strategies that align with Aldevron's long-term objectives and operational expansion within the pharmaceutical manufacturing landscape.

Thomas Foti, the President, Protein Business Unit at Aldevron, leads the strategic direction and operational execution for the protein division. Foti drives the development and commercialization of Aldevron's protein products, including enzymes and antibodies, essential for biotechnology research and therapeutic applications. This executive role involves overseeing product pipelines, market expansion, and customer engagement within the protein sector. The President of the Protein Business Unit ensures alignment with Aldevron's broader manufacturing capabilities for plasmid DNA and other biological materials. By focusing on innovation and quality, Thomas Foti enhances Aldevron's market position and contributes significantly to advancing scientific discovery and global health initiatives.

Jennifer Meade, the President at Aldevron, oversees key operational functions and strategic initiatives across the organization. Meade focuses on driving operational excellence and ensuring the efficient manufacturing of plasmid DNA, proteins, enzymes, and antibodies. This leadership role is integral to supporting Aldevron's mission of advancing biotechnology and impacting global health. The President works closely with other executive leaders to optimize production processes and enhance supply chain management. By championing quality and innovation, Jennifer Meade contributes to Aldevron's reputation as a trusted partner in the pharmaceutical manufacturing industry. Meade's leadership ensures the company's continued growth and its ability to meet the evolving needs of the scientific community.

Luis Gonçalves, the Vice President, Information Technology & Chief Information Officer at Aldevron, directs the company's technology strategy and infrastructure. Gonçalves oversees all aspects of information technology, including data management, cybersecurity, and digital transformation initiatives. This leadership position is vital for supporting Aldevron's complex manufacturing processes for plasmid DNA, proteins, enzymes, and antibodies. The Chief Information Officer ensures that technology systems enhance operational efficiency and data integrity, crucial for biotechnology advancements. By implementing cutting-edge IT solutions, Luis Gonçalves drives innovation and secures the company's digital assets. Gonçalves's strategic vision ensures Aldevron maintains a competitive technological edge, supporting its mission to impact global health research and development.